{
  "docId": "019de074-dee8-7497-a5f7-ae2745d7f9f6",
  "docSlug": "87d7e2eb7c56e30923dbf29903df5034",
  "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides",
  "authorId": "compass-therapeutics",
  "authorName": "Compass Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 27,
  "pageCount": 40,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "balanced",
  "nDataPoints": 10,
  "notes": "The slide uses a table for epidemiological data and a horizontal layout to represent the treatment pathway.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-dee8-7497-a5f7-ae2745d7f9f6/27",
  "deckHref": "/decks/019de074-dee8-7497-a5f7-ae2745d7f9f6",
  "deckJsonHref": "/decks/019de074-dee8-7497-a5f7-ae2745d7f9f6.json",
  "deckAnchorHref": "/decks/019de074-dee8-7497-a5f7-ae2745d7f9f6#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.97,
        "x": 0.014,
        "y": 0.54
      },
      "kind": "list",
      "text": "1L, 2L, and 3L treatment regimens including specific drugs and patient percentages.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3a0baa50-7857-4880-960e-578c451125b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.15,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "1. NCI Surveillance, Epidemiology, and End Results (SEER) program\n2. International Agency for Research on Cancer/GLOBOCAN\n3. L Biller, D Schrag, JAMA 2021 Feb 16\n4. Bekaii-Saab, Clin advances in Hem and Onc, Supp Jan 2021",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6eaca488-ec40-407a-9af3-61ce7858c5a1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.498,
        "w": 0.812,
        "x": 0.17,
        "y": 0.168
      },
      "kind": "table",
      "text": "Incident cases and metastatic patient estimates for US, EU5, Japan, and Worldwide.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b771f35b-c6ac-4e34-bd03-db0341d1fc25",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.03,
        "y": 0.07
      },
      "kind": "title",
      "text": "CTX-009: CRC Patient Demographics and Current Treatments",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc00dd93-5421-43f2-8a25-86f674e88f08",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Market Segmentation Pyramid",
      "slug": "market-segmentation-pyramid",
      "agent": null,
      "layer": "slide",
      "matchId": "baa59dcf-9fff-41aa-98eb-c81a75a0cc87",
      "evidence": "list/bullet: 1L, 2L, and 3L treatment regimens including specific drugs and patient percentages.",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 27,
      "from": 25,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "3678642e-dac1-42f2-95a1-7c436213b508",
      "evidence": "slides 25-27",
      "position": 0,
      "objective": "Highlight the cost of inaction in BTC treatment",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}